Post by ROTOP Pharmaka GmbH

We’re pleased to welcome 𝗠𝗶𝗰𝗵𝗮𝗲𝗹 𝗣𝗲𝘁𝗲𝗿𝘀𝗲𝗶𝗺 as our new 𝗖𝗵𝗶𝗲𝗳 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 (𝗖𝗙𝗢) at ROTOP. Michael Peterseim brings many years of experience in financial leadership and has successfully guided companies through transformation processes, strengthened performance, and executed strategic transactions, particularly in growth situations. He has worked in various B2B and B2C environments, including in leadership roles at Roland Berger, KaDeWe Group, Camp David, Grundig, and Thomas Cook. Most recently, he joins us from QE-3 Equity Partners. At #ROTOP, Michael will be responsible for Finance/Controlling, HR, and IT/Technology and will support the next phase of our growth, with a particular focus on process optimization and new construction investments. #WelcomeToTheTeam #FinanceLeadership #CFO #ExecutiveTeam #Radiopharmacy #NuclearMedicine #Theranostics #Radiopharmaceuticals #PrecisionMedicine #DiagnosticImaging #TargetedTherapy #NuclearDiagnostics #NuclearTherapy #HealthInnovation #ClinicalCare #HealthcareLogistics